What does Métamil do?

Métamil is a structural metal fabricator in Oupeye. Private Limited, started on 1 January 1968, 1 establishment.

What is the address of Métamil?

The registered office of Métamil is located at Rue Devant La Ville 35, 4680 Oupeye.

Is Métamil still active?

Not as usual. The CBE lists Métamil with legal situation “Vrijwillige ontbinding – vereffening”.

Is Métamil registered on Peppol?

Yes, Métamil is registered on the Peppol network with ID 0208:0404430018.

What is the enterprise number of Métamil?

The enterprise number of Métamil is BE0404430018.

When was Métamil founded?

Métamil was founded on 1 January 1968.

Who are the directors of Métamil?

According to the 2025 annual accounts, the directors of Métamil are: Hubert Jean TASSET.

Is Métamil a reliable company?

Databakkes does not pass judgement; this is what the sources say: Vrijwillige ontbinding – vereffening according to the CBE, started on 1 January 1968; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Métamil make in 2025?

Métamil posted a profit after taxes of € 16,148 in financial year 2025.

What is the revenue of Métamil?

As a small company, Métamil is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 20,833.

Métamil (Private Limited) - Oupeye - BE0404430018

Dossier Métamil, printed on 30 October 2026 from databakkes.be/en/0404430018/metamil. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Legal situation KBO

Vrijwillige ontbinding – vereffening according to the CBE.

Financials

Financial year 2025

Métamil from Oupeye, company number BE0404430018, closed financial year 2025 with a result of € 16,148 after tax. For that financial year Métamil recorded a gross margin of € 20,833 and equity of € 116,538. Compared with financial year 2024, the result moved from € 20,506 to € 16,148. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 31, 2026.

What it is worth Growing

€ 116,538

▲ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 16,148

▼ 21% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 88,108

▲ 34% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 108,932.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3,715

▲ 95% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 801

▼ 7% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 32,579 Gross margin 2022: € 32,579 First fiscal year in the series	€ 22,830 Gross margin 2023: € 22,830 ▼ 30% vs 2022 (€ 32,579) Unfavourable step	€ 25,053 Gross margin 2024: € 25,053 ▲ 10% vs 2023 (€ 22,830) Favourable step	€ 20,833 Gross margin 2025: € 20,833 ▼ 17% vs 2024 (€ 25,053) Unfavourable step	▼ 17%
Profit after taxes	€ 22,607 Profit after taxes 2022: € 22,607 First fiscal year in the series	€ 18,335 Profit after taxes 2023: € 18,335 ▼ 19% vs 2022 (€ 22,607) Unfavourable step	€ 20,506 Profit after taxes 2024: € 20,506 ▲ 12% vs 2023 (€ 18,335) Favourable step	€ 16,148 Profit after taxes 2025: € 16,148 ▼ 21% vs 2024 (€ 20,506) Unfavourable step	▼ 21%
Equity	€ 61,549 Equity 2022: € 61,549 First fiscal year in the series	€ 79,884 Equity 2023: € 79,884 ▲ 30% vs 2022 (€ 61,549) Favourable step	€ 100,390 Equity 2024: € 100,390 ▲ 26% vs 2023 (€ 79,884) Favourable step	€ 116,538 Equity 2025: € 116,538 ▲ 16% vs 2024 (€ 100,390) Favourable step	▲ 16%
Total debts	€ 11,057 Total debts 2022: € 11,057 First fiscal year in the series	€ 12,061 Total debts 2023: € 12,061 ▲ 9% vs 2022 (€ 11,057) Unfavourable step	€ 2,892 Total debts 2024: € 2,892 ▼ 76% vs 2023 (€ 12,061) Favourable step	€ 5,529 Total debts 2025: € 5,529 ▲ 91% vs 2024 (€ 2,892) Unfavourable step	▲ 91%
Cash	€ 32,033 Cash 2022: € 32,033 First fiscal year in the series	€ 57,328 Cash 2023: € 57,328 ▲ 79% vs 2022 (€ 32,033) Favourable step	€ 65,952 Cash 2024: € 65,952 ▲ 15% vs 2023 (€ 57,328) Favourable step	€ 88,108 Cash 2025: € 88,108 ▲ 34% vs 2024 (€ 65,952) Favourable step	▲ 34%
Retained profit	€ 53,943 Retained profit 2022: € 53,943 First fiscal year in the series	€ 72,278 Retained profit 2023: € 72,278 ▲ 34% vs 2022 (€ 53,943) Favourable step	€ 92,785 Retained profit 2024: € 92,785 ▲ 28% vs 2023 (€ 72,278) Favourable step	€ 108,932 Retained profit 2025: € 108,932 ▲ 17% vs 2024 (€ 92,785) Favourable step	▲ 17%
Balance sheet total	€ 72,606 Balance sheet total 2022: € 72,606 First fiscal year in the series	€ 91,945 Balance sheet total 2023: € 91,945 ▲ 27% vs 2022 (€ 72,606) Unchanged	€ 103,282 Balance sheet total 2024: € 103,282 ▲ 12% vs 2023 (€ 91,945) Unchanged	€ 122,067 Balance sheet total 2025: € 122,067 ▲ 18% vs 2024 (€ 103,282) Unchanged	▲ 18%

Key figures of Métamil, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to Métamil?

What happened at Métamil in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Métamil is active according to the CBE. Legal situation: Vrijwillige ontbinding – vereffening.

Jan 31, 2026 New annual accounts for financial year 2025: profit of € 16,148 (▼ 21% vs 2024). filed late Source: NBB ↗
2019 Hubert Jean TASSET became a director. NBB
Jan 1, 1968 Start of the company according to the CBE. KBO
Nov 1, 1961 New establishment in Oupeye. KBO

In short

From € 22,607 profit in 2022 to € 16,148 profit in 2025.

Paid € 4,060 in corporate taxes since 2022.

Best year ever: 2022, with € 22,607 profit.

Original PDFs at the National Bank ↗

Management

HOLDING 61 99.6%

The stake of HOLDING 61 comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Métamil

Behind Métamil is Hubert Jean TASSET. The shares are held by HOLDING 61 (99.6%).

Directors

According to the 2025 annual accounts

Hubert Jean TASSET

Liquidator

since 2019

Shareholders

HOLDING 61

99.6%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Devant La Ville 35

4680 Oupeye

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

COGEGAZ-FM

€ 687,528 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0404.430.018

VAT number

BE 0404.430.018

Registered office

Rue Devant La Ville 35, 4680 Oupeye

Names & denominations

Métamil

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Vrijwillige ontbinding – vereffening

Start date

1 January 1968

Peppol

Active · Active since 30 Dec 2025

Activities · NACE

Vervaardiging van metalen constructiewerken en delen daarvan

Vervaardiging van metalen constructiewerken en onderdelen daarvan

Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen

View on CBE Public ↗ Annual accounts (NBB) ↗

Métamil

Warning lights

Financials

What happened to Métamil?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions